Cyclopharm News and Activities

Cyclopharm is a company listed under the stock ticker CYC (AU).

View the org chart displaying its 13 main executives

Most searched biographies at Cyclopharm

• James Mcbrayer, Chief Executive Officer
• Kevin Barrow, Non Executive Director
• Doug Cubbin, Non-Executive Director

Popular executive movements at Cyclopharm

• David Heaney, Chairman and Non-Executive Director, will leave the company on May 8, 2026  (posted on May 4 2026).
• Doug Cubbin has joined the company as Non-Executive Director  (posted on May 4 2026).
• John Macq, Non Executive Director, has left the company  (posted on April 7 2026).

Click here to view some more movements at Cyclopharm

Create your alert
to follow the executive moves at Cyclopharm.

Cyclopharm has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Cyclopharm

• Press releases - Cyclomedica
• Resource library - Cyclomedica

Social media about Cyclopharm

• Cyclopharm on Wikipedia, Google News & Yahoo Finance
• Cyclopharm on LinkedIn, X (Twitter) & YouTube